| Funding opportunities and news for global health researchers from the Fogarty International Center at the U.S. National Institutes of Health. 
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week. Funding Opportunities NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply. - Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) (RFA-AI-21-009)
Application Receipt Date(s): Multiple dates, see announcement. - Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) (RFA-AI-21-012)
Application Receipt Date(s): Multiple dates, see announcement. - 2021 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2021-1 Now Available (NOT-AI-21-045)
Solicits proposals that possess the research and development (R&D) expertise necessary for successfully carrying out research toward meeting the program objectives of the Division of Microbiology and Infectious Diseases (DMID), NIAID, NIH.
Contract Proposal Receipt Date: May 24, 2021 - Research on Autism Spectrum Disorders (R03 Clinical Trial Optional) (PA-21-199), (R21 Clinical Trial Optional) (PA-21-200) and (R01 Clinical Trial Optional) (PA-21-201)
Application Receipt Date(s): Multiple dates, see announcement. - Post-Acute Interventions and Services to Optimize Longer-term Outcomes from the National Institute of Mental Health (NIMH)
Effectiveness Trials (R01 Clinical Trial Required) (PAR-21-210)
Pilot Effectiveness Trials (R34 Clinical Trial Required) (PAR-21-211)
Application Receipt Date(s): Multiple dates, see announcement. - Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) (RFA-HG-21-006), (R21 Clinical Trial Not Allowed) (RFA-HG-21-007) and (R43/R44) (RFA-HG-21-008)
Application Receipt Date(s): June 25, 2021; March 1, 2022; February 1, 2023 NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers. - Deciphering the Mosaic of Glia in the Addicted Brain (NOT-DA-21-001)
- Identification of Biomarkers of HIV Pathogenesis and Substance Use Disorder Comorbidity (NOT-DA-21-014)
- Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01, R21) (NOT-HD-21-024)
- COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children (NOT-MH-21-225)
Funding opportunities that may be of interest to global health researchers from other U.S. Government agencies. - Cleaner Air and Better Health (CABH) from India USAID-New Delhi via Grants.gov. USAID/India will support the Government of India (GOI) to strengthen air pollution mitigation and exposure reduction systems in selected regions of India, contributing to a cleaner environment and healthier population.
Application deadline: September 30, 2021 | Featured Fogarty News and Information NIH COVID-19 Funding and News | Funding News NIH funding news that may be relevant to global health researchers. - Reminders of NIH Policies Related to Closeout (NOT-OD-21-102)
- Registration is Now Open for the 2021 HHS Small Business Program Conference on April 26-30! (NOT-OD-21-098)
- Notice of Intent to Publish the Reissuance of BRAIN Initiative: Novel Technologies and Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (NOT-NS-21-051) and (U01 Clinical Trials Not Allowed) (NOT-NS-21-052)
Upcoming Deadlines
| This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: Fogarty International Center at NIH · National Institutes of Health · Bethesda, MD 20892 · (301) 496-2075 · ficinfo@mail.nih.gov |  | |
No comments:
Post a Comment